Role Of Antioxidant Therapy In Management Of Type – 2 Diabetes Mellitus
Role Of Antioxidant Therapy In Management Of Type – 2 Diabetes Mellitus
Keywords:
Type 2 Diabetes Mellitus , Vitamin C, Vitamin E, AntioxidantAbstract
Introduction: Diabetes Mellitus is a heterogeneous group of disorders characterized by variable degrees of insulin resistance, impaired insulin secretion and increased glucose production. Free radical injury is important contributing factor for the development of Insulin resistance and impaired insulin secretion. Recently it has been suggested that glycation of antioxidant enzymes could alter the structure and function of antioxidant enzymes such that they are unable to detoxify free radicals. Intake of vitamin E and vitamin C, due to antioxidant property, is associated with reduced risk of development of Diabetes Mellitus Type 2. With this background, this study was planned to explore the role of antioxidant therapy in the management of Diabetes Mellitus Type 2. Objectives: (1) To demonstrate increased oxidative stress in newly diagnosed Type 2 Diabetes Mellitus patients by measuring antioxidant enzymes activities. (2) To study the effect of oral hypoglycaemic agents on oxidative stress in Type 2 Diabetes Mellitus patients. (3) To evaluate the effects of vitamin C, vitamin E and their combination in patients having Type 2 Diabetes Mellitus managed with oral hypoglycaemic agents. Materials and Methods: The study included two groups consisting of 60 euglycemic healthy subjects and 64 newly diagnosed Diabetes Mellitus Type 2 patients. After 3 months of treatment with oral hypoglycaemic drug, the second group was divided into 4 subgroups with 16 subjects in each subgroup and were treated with oral hypoglycaemic agent alone, oral hypoglycaemic agent + vitamin C, oral hypoglycaemic agent + vitamin E, and oral hypoglycaemic agent + vitamin C + vitamin E respectively for further 3 months. Results : Hyperglycemia in patients with Diabetes Mellitus Type 2 is associated with reduced antioxidant status (superoxide dismutase and catalase activities, and reduced glutathione level). Treatment with oral hypoglycaemic agent for 3 months produced euglycemia with partial but statistically significant elevation of catalase activity and reduced glutathione level in blood. Following additional antioxidant therapy with vitamin C and vitamin E produced further significant increase in reduced glutathione level, however fasting plasma glucose level and activities of superoxide dismutase and catalase enzymes were found to be statistically non-significant.Conclusion: Antioxidant therapy with vitamin C and vitamin E in addition to oral hypoglycaemic agent reduces oxidative stress in patients having Type 2 Diabetes Mellitus
References
2. Wiernsperger N.F. Oxidative stress as a therapeutic target in diabetes : revisiting the controversy. Diabetes Metab, 2003, 29 : 579 – 585.
3. E. Wright et al. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. International journal of clinical practice, Vol. 60, No. 3. (March 2006), pp. 308-314.
4. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Are oxidative stress activated signaling pathways mediators of insulin resistance and β – cell dysfunction ? Diabetes, 2003, 52 : 1 – 8.
5. Robertson R.P., Jamie Harmon, Phuong O.T., Yoshito Tanaka, and Hiroki Takahashi. Glucose toxicity in β- cells : Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes, 2003, 52 : 581 – 587.
6. Giugliano D, Ceriello A, Paolisso G . Oxidative stress and diabetic vascular complications. Diabetes care, 1996, 19 : 257 – 267.
7. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Greager M.A. Impaired endothelium dependent vasodilation in patients with insulin dependent diabetes mellitus. Circulation , 1993, 88 :2510-2516.
8. Sharma A, Simmi K, Chungh S, Kakkar R, Singh G. Effect of glycemic control and vitamin E supplementation on total glutathione content in NIDDM. Annuals of nutrition & metabolism, 2000, 44 : 11 – 13
9. Jacob S, Ruus P, Hermann R, Tritschler H.J., Maerker E, Renn W, Augustin H.J. et al. Oral administration of RAC – α – lipoic acid modulates insulin sensitivity in patients with Type 2 Diabetes Mellitus : a placebo controlled pilot trial. Free Radic Biol Med, 1999, 27 : 309 – 314.10. Vijayalingam S, Parthiban A, Shanmugasundaram K, Mohan V. Abnormal antioxidant status in impaired glucose tolerance and NIDDM. Diabetic Medicine,1996,12 : 715-719.
11. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. New York, Oxford University Press, 1989.
12. Paolisso G, A D’Amore, D Galzerano, V Balbi, D Giugliano, M Varricchio et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly Type 2 Diabetes Mellitus patients .Diabetes care, 1993, 16 : 1433 – 1437.
13. Paolisso G., A D ‘ Amore, V. Balbi, C. Volpe, D. Galzerano, D. Giugliano et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol Endocrinol Metab, 1994,266 : E261-E268.
14. Azzi A, Ricciarelli R, Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherols (vitamin E).FBS Lett.,2002,519:8-10
15. Griffin M.E., Marcucci M.J., Cline G.W., Bell K, Barucci N, Lee D et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C and alterations in insulin signaling cascades. Diabetes, 1999, 48 : 1270-1274.
16. Kowluru R.A., Kennedy A. Therapeutic potential of antioxidants and diabetic retinopathy. Expert Opin Investing Drugs, 2001, 10 : 1665 – 1676.
17. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witzum J.L. Beyond cholesterol : modifications of LDL that increase its atherogenicity. N Engl J Med , 1989, 320 : 915-924.
18. Andrew R, Skyrme-Jones P, O’Brien R.C., Berry K.L.., Meredith I.T. Vitamin E supplementation improves endothelial functioin in Type 1 Diabetes Mellitus : a randomized placebo controlled study. J Am Coll Cardiol , 2000, 36 : 94-102.
19. Bursell S.E., Clermont A.C., Aiello L.P., Schlossman D.K., Feener E.P., Laffel L. High dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patient
with Type 1 Diabetes Mellitus. Diabetes Care, 1999, 22 : 1245-1251.
20. Kuroki T, Isshiki K, and G.L. King. Oxidative stress : The lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol, 2003, 14 : 216-220.
